Solitek brings a new concept in solid state development: crystallization, polymorphism, cocrystals, salt selection, preformulation and solubility studies. Combining an excellent understanding of the diversity of the solid form landscape exhibited by small molecule organic compounds with experience and practical know-how, Solitek can increase your chances of success, while reducing the overall cost of development.
Solitek offers the advice you need, relevant to your requirements, to help reduce the risk of failure during the later development stages and to maximise the returns from potential out-licensing opportunities. Solitek promotes collaboration over competition and believes in the synergy of two teams working together towards a common goal.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Parc Cientific De Barcelona, C/ Baldiri Reixac 10-12,spain
- Industry
- Research
- Website
- http://www.solitekpharma.com
- Keywords
- Crystallization Development, Solid Form Screening and Selection, Small Molecule, Early Development, Polymorphism, Salts and Cocrystals, Solid State Training, Preformulation, Solubility, Particle Size.
- HQ
- Barcelona, Barcelona
Solitek - Solid Technologies Sl Questions
Solitek - Solid Technologies Sl's website is http://www.solitekpharma.com
Solitek - Solid Technologies Sl's LinkedIn profile is https://es.linkedin.com/company/solitekpharma
Solitek - Solid Technologies Sl has
8 employees.
View email and phone details for 8
employees at Solitek - Solid Technologies Sl.
Solitek - Solid Technologies Sl's industry is
Research
Solitek - Solid Technologies Sl's top competitors are
Enantia,
Bellen Chemistry Co., Ltd.,
Nanomol Technologies,
Esteve Química, S.a.,
Solitek,
Arcinova - A Quotient Sciences Company,
Chapta,
Xtalpi Inc.,
Solitek,
Cy Partners.
Solitek - Solid Technologies Sl's categories are Research
Solitek - Solid Technologies Sl's founding year is 2021
